• Je něco špatně v tomto záznamu ?

Longitudinal subtypes of disordered gambling in young adults identified using mixed modeling

SR. Chamberlain, J. Stochl, JE. Grant

. 2020 ; 97 (-) : 109799. [pub] 20191030

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012803

Grantová podpora
Wellcome Trust - United Kingdom
110,049/Z/15/Z Wellcome Trust - United Kingdom
Department of Health - United Kingdom

OBJECTIVE: While many individuals gamble responsibly, some develop maladaptive symptoms of a gambling disorder. Gambling problems often first occur in young people, yet little is known about the longitudinal course of such symptoms and whether this course can be predicted. The aim of this study was to identify latent subtypes of disordered gambling based on symptom presentation and identify predictors of persisting gambling symptoms over time. METHODS: 575 non-treatment seeking young adults (mean age [SD] = 22.3 [3.6] years; 376 (65.4%) male) were assessed at baseline and annually, over three years, using measures of gambling severity. Latent subtypes of gambling symptoms were identified using latent mixture modeling. Baseline differences were characterized using analysis of variance and binary logistic regression respectively. RESULTS: Three longitudinal phenotypes of disordered gambling were identified: high harm group (N = 5.6%) who had moderate-severe gambling disorder at baseline and remained symptomatic at follow-up; intermediate harm group (19.5%) who had problem gambling reducing over time; and low harm group (75.0%) who were essentially asymptomatic. Compared to the low harm group, the other two groups had worse baseline quality of life, elevated occurrence of other mental disorders and substance use, higher body mass indices, and higher impulsivity, compulsivity, and cognitive deficits. Approximately 5% of the total sample showed worsening of gambling symptoms over time, and this rate did not differ significantly between the groups. CONCLUSIONS: Three subtypes of disordered gambling were found, based on longitudinal symptom data. Even the intermediate gambling group had a profundity of psychopathological and untoward physical health associations. Our data indicate the need for large-scale international collaborations to identify predictors of clinical worsening in people who gamble, across the full range of baseline symptom severity from minimal to full endorsement of current diagnostic criteria for gambling disorder.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012803
003      
CZ-PrNML
005      
20210507104244.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.pnpbp.2019.109799 $2 doi
035    __
$a (PubMed)31676469
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Chamberlain, Samuel R $u Department of Psychiatry, University of Cambridge, UK; Cambridge and Peterborough NHS Foundation Trust, UK
245    10
$a Longitudinal subtypes of disordered gambling in young adults identified using mixed modeling / $c SR. Chamberlain, J. Stochl, JE. Grant
520    9_
$a OBJECTIVE: While many individuals gamble responsibly, some develop maladaptive symptoms of a gambling disorder. Gambling problems often first occur in young people, yet little is known about the longitudinal course of such symptoms and whether this course can be predicted. The aim of this study was to identify latent subtypes of disordered gambling based on symptom presentation and identify predictors of persisting gambling symptoms over time. METHODS: 575 non-treatment seeking young adults (mean age [SD] = 22.3 [3.6] years; 376 (65.4%) male) were assessed at baseline and annually, over three years, using measures of gambling severity. Latent subtypes of gambling symptoms were identified using latent mixture modeling. Baseline differences were characterized using analysis of variance and binary logistic regression respectively. RESULTS: Three longitudinal phenotypes of disordered gambling were identified: high harm group (N = 5.6%) who had moderate-severe gambling disorder at baseline and remained symptomatic at follow-up; intermediate harm group (19.5%) who had problem gambling reducing over time; and low harm group (75.0%) who were essentially asymptomatic. Compared to the low harm group, the other two groups had worse baseline quality of life, elevated occurrence of other mental disorders and substance use, higher body mass indices, and higher impulsivity, compulsivity, and cognitive deficits. Approximately 5% of the total sample showed worsening of gambling symptoms over time, and this rate did not differ significantly between the groups. CONCLUSIONS: Three subtypes of disordered gambling were found, based on longitudinal symptom data. Even the intermediate gambling group had a profundity of psychopathological and untoward physical health associations. Our data indicate the need for large-scale international collaborations to identify predictors of clinical worsening in people who gamble, across the full range of baseline symptom severity from minimal to full endorsement of current diagnostic criteria for gambling disorder.
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a hráčství $x klasifikace $7 D005715
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a psychologické modely $7 D008960
650    _2
$a fenotyp $7 D010641
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Stochl, Jan $u Department of Psychiatry, University of Cambridge, UK; Department of Kinanthropology, Charles University in Prague, Czechia; Cambridge and Peterborough NHS Foundation Trust, UK. Electronic address: js883@cam.ac.uk
700    1_
$a Grant, Jon E $u Department of Psychiatry & Behavioral Neuroscience, University of Chicago, United States of America. Electronic address: jongrant@uchicago.edu
773    0_
$w MED00003930 $t Progress in neuro-psychopharmacology & biological psychiatry $x 1878-4216 $g Roč. 97, č. - (2020), s. 109799
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31676469 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507104243 $b ABA008
999    __
$a ok $b bmc $g 1651048 $s 1133182
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 97 $c - $d 109799 $e 20191030 $i 1878-4216 $m Progress in neuro-psychopharmacology & biological psychiatry $n Prog Neuropsychopharmacol Biol Psychiatry $x MED00003930
GRA    __
$p Wellcome Trust $2 United Kingdom
GRA    __
$a 110,049/Z/15/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$p Department of Health $2 United Kingdom
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...